S&P 500
5,912.32
+1.9%
+$109.50
DJI
42,296.66
+1.7%
+$693.59
NASDAQ
19,156.46
+2.2%
+$419.25
Bitcoin
109,694.00
+0.6%
+668.68
AAPL
$200.13
+2.5%
+$4.86
AMZN
$205.42
+2.2%
+$4.43
GOOG
$173.91
+2.5%
+$4.32
META
$640.98
+2.2%
+$13.92
MSFT
$459.38
+2.0%
+$9.20
NVDA
$134.81
+2.7%
+$3.52
TSLA
$360.36
+6.2%
+$21.02
Dermata Therapeutics (NASDAQ: DRMA)
$0.76
(-1.6%)
-$0.01
Price as of May 22, 2025, 2:14 p.m. ET
Dermata Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Dermata Therapeutics Company Info
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.